It is possible, if you lay the groundwork, to provide patients with acute leukemias with aggressive and effective therapies, while still allowing them to maintain quality of life, explained Jennifer Vaughn, MD, of The Ohio State University Comprehensive Cancer Center – James Cancer Hospital.
Read More
Dr Jennifer Vaughn: Patients With MPN, MDS Should Discuss Long-Term Priorities Upfront
March 1st 2024For many patients with myeloproliferative neoplasms (MPNs) and myelodysplastic syndromes (MDS), their disease will be chronic, giving them a long-term cancer experience, said Jennifer Vaughn, MD, of The Ohio State University Comprehensive Cancer Center – James Cancer Hospital.
Read More
Dr Alma Habib: Effort Needs to Be Put Into Addressing Disparities in Leukemia, Lymphoma Care
October 15th 2023Alma Habib, MD, The Ohio State University Comprehensive Cancer Center, talks about the fact that disparities are able to be recognized in leukemia/lymphoma care, but the questions of how to address these disparities remain.
Read More
Dr Sarah Wall: Challenges Faced by Older Patients With Hematologic Disorders
October 14th 2023Older patients often face financial challenges on fixed incomes with different payer systems like Medicare, Sarah Wall, MD, The Ohio State University Comprehensive Cancer Center, says. Accessing treatment centers far away is difficult due to support system disruptions, leading to increased stress and financial strain.
Read More
Dr Jay Lee: NSCLC Recurrence More Costly Than Patients Who Don’t Experience Recurrence
October 11th 2023Jay Lee, MD, talks about financial toxicity in terms of the individual patient and in terms of the health system itself, especially in terms of non-small cell lung cancer (NSCLC) recurrence.
Read More
Dr Andrew Ho: After PE Hospitalization, It’s Important to Look Into Logistical Options for Patients
October 10th 2023Andrew Ho, MD, talks about the importance of searching for what can be modified, such as closer transition to skilled nursing facilities, when working with patients who had pulmonary embolism (PE) and experienced readmission who had nonmodifiable factors and comorbidities.
Read More
Dr Aparna Balasubramanian Discusses Necessary Care of High-Risk Patients With COPD
October 10th 2023Aparna Balasubramanian, MD, discusses the importance of measurements such as heart rate variability, but also that there’s no such thing as just 1 biomarker that will give all information for high-risk patients with chronic obstructive pulmonary disease (COPD).
Read More
Dr Sarah Wall: Putting Attention on Older Adults With Blood-Based Cancer Is Vital Moving Forward
October 10th 2023Sarah Wall, MD, talks about how it’s important to consider patient age when treating older patients with cancer because it will impact so many of them and blood cancers act differently and can be more aggressive in older adults.
Read More
Digging Into the Increasing Lung Cancer Rate for Female, Asian, Never Smokers: Dr Jeffrey Velotta
October 9th 2023Jeffrey Velotta, MD, FACS, attendee and presenter of CHEST Annual Meeting 2023, talks about the phenomenon of an increase in female, Asian, nonsmokers developing lung cancer, and what is being done to address this rise.
Read More
It’s Important to Challenge Assumptions in Pulmonary Care, Says Dr Aparna Balasubramanian
October 9th 2023Aparna Balasubramanian, MD, assistant professor of medicine, Johns Hopkins School of Medicine, and attendee of the CHEST Annual Meeting 2023, talks about the necessity of challenging measurements like race-specific equations that can create harmful assumptions.
Read More
Biosimilars Could Help With Increasing Costs for AMD Therapies in Medicare
September 29th 2023Drug maker payments to ophthalmologists were associated with the choice of higher-cost therapies for age-related macular degeneration (AMD) that could increase Medicare costs, but biosimilars could help.
Read More
Adalimumab Plus Surgery Delivers Better Outcomes Than Adalimumab Alone for HS
September 19th 2023Adalimumab in conjunction with surgery demonstrated more clinical effectiveness and improved quality of life in patients with hidradenitis suppurativa (HS) compared with outcomes in those treated with adalimumab alone.
Read More
Novel, Automated Ventilatory Burden Measure Shows Promise to Gauge OSA Severity
September 12th 2023Automated ventilatory burden can effectively assess obstructive sleep apnea (OSA) severity, estimate cardiovascular (CVD) mortality, and may present a promising alternative to apnea-hypopnea index (AHI).
Read More